Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
UBS
Fish and Richardson
Daiichi Sankyo
Boehringer Ingelheim
Cipla
Medtronic
Citi
Express Scripts

Generated: May 24, 2018

DrugPatentWatch Database Preview

METHDILAZINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Methdilazine Hydrochloride patents expire, and what generic alternatives are available?

Methdilazine Hydrochloride is a drug marketed by Alpharma Us Pharms and is included in one NDA.

The generic ingredient in METHDILAZINE HYDROCHLORIDE is methdilazine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the methdilazine hydrochloride profile page.
Summary for METHDILAZINE HYDROCHLORIDE
Drug patent expirations by year for METHDILAZINE HYDROCHLORIDE
Synonyms for METHDILAZINE HYDROCHLORIDE
10-((1-Methyl-3-pyrrolidinyl)methyl)phenothiazine monohydrochloride
10-((1-Methyl-3-pyrrolidinyl)methyl)phenothiazine, hydrochloride
10-((1-Methylpyrrolidin-3-yl)methyl)-10H-phenothiazine hydrochloride
10-((1-Methylpyrrolidin-3-yl)methyl)-10H-phenothiazinehydrochloride
10-(1-Methyl-3-pyrroldiylmethyl)phenothiazine hydrochloride
10-[(1-Methyl-3-pyrrolidinyl)methyl]-10H-phenothiazine Hydrochloride
10-[(1-Methyl-3-pyrrolidinyl)methyl]phenothiazine hydrochloride
10-[(1-methylpyrrolidin-3-yl)methyl]-10H-phenothiazine hydrochloride
10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine hydrochloride
10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine;hydrochloride
10H-Phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-, monohydrochloride
10H-Phenothiazine, 10-[(1-methyl-3-pyrrolidinyl)methyl]-, monohydrochloride
1229-35-2
1982-37-2 (Parent)
AC1L24C3
AK129791
AKOS016014016
API0009065
AX8137692
Bristaline
C18H20N2S
C18H21ClN2S
CAS-1229-35-2
CCRIS 6256
CHEMBL1200532
D04980
Dilosyn
Disyncran
DSSTox_CID_5548
DSSTox_GSID_25548
DSSTox_RID_77825
DTXSID3025548
EINECS 214-967-3
FT-0671130
HSDB 5192
IEISBKIVLDXSMZ-UHFFFAOYSA-N
KB-217583
LS-673
Methdilazine Hcl
METHDILAZINE HYDROCHLORIDE (200 MG)
Methdilazine hydrochloride (USP)
Methdilazine hydrochloride [USP]
Methdilazine monohydrochloride
MJ 5022
NCGC00014482-01
NSC 169091
NSC-169091
NSC169091
Phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-, hydrochloride
Phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-, monohydrochloride
Q810
SCHEMBL211226
Tacaryl hydrochloride
Tacaryl hydrochloride (TN)
Tox21_110047
WLN: T C666 BN ISJ B1- CT5NTJ A1 &GH

US Patents and Regulatory Information for METHDILAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms METHDILAZINE HYDROCHLORIDE methdilazine hydrochloride SYRUP;ORAL 087122-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
Federal Trade Commission
Fuji
Cerilliant
Farmers Insurance
Accenture
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.